Compare IDEXX Laboratories, Inc. (IDXX) vs Cloudflare Inc (NET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Cloudflare Inc — how do they compare? IDEXX Laboratories, Inc. trades at $552.09 (market cap $44.48B), while Cloudflare Inc trades at $273.6 (market cap $96.69B). The key difference: Cloudflare Inc is far larger — about 2.2× IDEXX Laboratories, Inc.'s market cap, and Cloudflare Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | NET | |
|---|---|---|
Market Cap | $44.48B | $96.69B |
Sector | Health | Technology |
52-Week High | $766.68 | $281.69 |
52-Week Low | $520.87 | $160.16 |
Enterprise Value | $45.38B | $96.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Cloudflare (NET) trades at $275.19, down 0.87% on the day, as the stock consolidates near recent highs. The company continues to demonstrate strong revenue growth with Q1 2026 earnings beating expectations, though it remains unprofitable with a -3.72% net margin. Technical indicators show a bullish trend with the stock trading above key support levels, while analyst sentiment remains positive with 72.5% recommending Buy. Recent product launches including Precursor behavioral defense highlight ongoing innovation in cybersecurity.
Outlook remains cautiously optimistic as Cloudflare leverages AI-driven cybersecurity demand, though profitability concerns and high valuations (P/S 41.75) present risks. The stock trades below consensus price target of $265.07, suggesting potential upside if execution continues. Key risks include intense competition and the company's ability to achieve sustainable profitability amid significant infrastructure investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →
